Liver disease in kidney transplant patients receiving azathioprine.
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000681:Amylases / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001803:Blood Transfusion; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002648:Child; D003404:Creatinine / Q000097:blood; D005260:Female; D006506:Hepatitis A / Q000209:etiology; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007958:Leukocyte Count; D008107:Liver Diseases / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D006511:Hepatitis B Antigens; D003404:Creatinine; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D000681:Amylases; D001379:Azathioprine; D001663:Bilirubin